52 - 3 82.23 Mill. I think Candela Corp. is a short because it's leading product, the GentleLASE laser system, is experiencing intense competition from rival manufacturers and should not be able to sustain for Candela recently achieved revenue growth rates. Management may be lying about the contribution to revenues from Cryogen sales, where, incidentally, a price war is currently underway. In addition, Candela is thought of, by a competitor, to be violating anti-trust regulations with regard to Cryogen sales. Business Description .
Candela develops, manufactures and distributes cosmetic laser and cryosurgical systems.
Over its operating history it has often been first to market with new technologies that have later been improved upon by competitors. Doug Harper, having signed the purchase agreement for PSSI between them and Candela, was the only person with whom I spoke that had anything necessarily positive to say about Candela. Others with whom I spoke were very doubtful of Candela's long term success as well as the truthfulness of management. Dr. Richard Sharpe has collected evidence with which he wishes to sue Candela for anti-trust violations regarding the sale of Cryogen. The company has introduced a plethora of products all targeted to the market of dermatology and cosmetic surgery.